Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription

Articles published in
Am Heart J
    July 2023
  1. ARAKI T, Kondo T, Imaizumi T, Sumita Y, et al
    Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support.
    Am Heart J. 2023;261:109-123.
    >> Share

    June 2023
  2. WANG X, Guo R, Guo Y, Guo Q, et al
    Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI.
    Am Heart J. 2023;260:9-17.
    >> Share

    May 2023
  3. ATALLAH J, Chiha T, Chen C, Siller-Matula JM, et al
    Clinical Outcomes Associated with Type II Myocardial Infarction Caused by Bleeding.
    Am Heart J. 2023 May 16:S0002-8703(23)00119-9. doi: 10.1016/j.ahj.2023.
    >> Share

  4. SHAH NP, Peterson ED, Page C, Blanco R, et al
    Generalizability of an EHR-Network Dataset to the United States for Cardiovascular Disease Conditions: Comparison of Cerner Real World Data with the National Inpatient Sample.
    Am Heart J. 2023 May 15:S0002-8703(23)00120-5. doi: 10.1016/j.ahj.2023.
    >> Share

  5. HANER JD, Rohla M, Losdat S, Iglesias JF, et al
    Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials.
    Am Heart J. 2023 May 14:S0002-8703(23)00115-1. doi: 10.1016/j.ahj.2023.
    >> Share

  6. ANANTH CV, Rutherford C, Rosenfeld EB, Brandt JS, et al
    Epidemiologic Trends and Risk Factors Associated with the Decline in Mortality from Coronary Heart Disease in the United States, 1990-2019.
    Am Heart J. 2023 May 11:S0002-8703(23)00117-5. doi: 10.1016/j.ahj.2023.
    >> Share

  7. ARNOLD SV, Gosch K, Kosiborod M, Wong ND, et al
    Contemporary Use of Cardiovascular Risk Reduction Strategies in Type 2 Diabetes. Insights from The Diabetes Collaborative Registry.
    Am Heart J. 2023 May 8:S0002-8703(23)00112-6. doi: 10.1016/j.ahj.2023.
    >> Share

    April 2023
  8. LI N, Chen R, Li J, Zhao X, et al
    Prognostic significance of serial NT-proBNP levels in patients with acute myocardial infarction: A prospective study.
    Am Heart J. 2023 Apr 26:S0002-8703(23)00110-2. doi: 10.1016/j.ahj.2023.
    >> Share

  9. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
    Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
    Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
    >> Share

  10. CHIUSOLO S, Bork CS, Gentile F, Lundbye-Christensen S, et al
    Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction.
    Am Heart J. 2023 Apr 20:S0002-8703(23)00089-3. doi: 10.1016/j.ahj.2023.
    >> Share

  11. BROWN JY, Drakeley S, Duncan M, Knapp WP, et al
    Moderate Intensity Exercise in Pregnant Patients with Cardiovascular Disease: A Pilot Study.
    Am Heart J. 2023 Apr 16:S0002-8703(23)00090-X. doi: 10.1016/j.ahj.2023.
    >> Share

  12. HUANG D, Gong Y, Fan Y, Zheng B, et al
    Coronary Angiography-Derived Index for Assessing Microcirculatory Resistance in Patients with Non-Obstructed Vessels: The FLASH IMR Study.
    Am Heart J. 2023 Apr 11:S0002-8703(23)00088-1. doi: 10.1016/j.ahj.2023.
    >> Share

  13. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    >> Share

  14. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    >> Share

  15. AUER J, Lamm G
    Blood pressure control in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:186-189.
    >> Share

  16. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
    Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
    Am Heart J. 2023;258:49-59.
    >> Share

    March 2023
  17. CHA JJ, Hong SJ, Kim JH, Lim S, et al
    Effect of rosuvastatin 20mg versus rosuvastatin 5mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00064-9. doi: 10.1016/j.ahj.2023.
    >> Share

  18. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    >> Share

  19. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
    A Randomized Controlled Trial of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients with Elevated Risk for Cardiovascular Disease: Rationale and Design of the BE ACTIVE Study.
    Am Heart J. 2023 Mar 2:S0002-8703(23)00048-0. doi: 10.1016/j.ahj.2023.
    >> Share

  20. DEFILIPPIS AP, Lidani KCF, Nam Y, Trainor PJ, et al
    Risk Factor Associations with Individual Myocardial Infarction Subtypes and Acute Non-Ischemic Myocardial Injury in the Multi-Ethnic Study of Atherosclerosis (MESA): Design and Rationale.
    Am Heart J. 2023 Mar 1:S0002-8703(23)00047-9. doi: 10.1016/j.ahj.2023.
    >> Share

    February 2023
  21. CASTELIJNS MC, Hageman SHJ, Teraa M, van der Meer MG, et al
    External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.
    Am Heart J. 2023 Feb 23:S0002-8703(23)00046-7. doi: 10.1016/j.ahj.2023.
    >> Share

  22. DAVIDSON SJ, Roncalli J, Surder D, Corti R, et al
    Microvascular Obstruction Identifies a Subgroup of Patients Who Benefit from Stem Cell Therapy Following ST-Elevation Myocardial Infarction.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00037-6. doi: 10.1016/j.ahj.2023.
    >> Share

  23. SCOCCIA A, Byrne RA, Banning AP, Landmesser U, et al
    Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization. Rationale and study design of the prospective randomized FAST III Trial.
    Am Heart J. 2023 Feb 14:S0002-8703(23)00036-4. doi: 10.1016/j.ahj.2023.
    >> Share

  24. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    >> Share

  25. KAUL U, Arambam P, Sinha SK, Abhaichand R, et al
    Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
    Am Heart J. 2023;256:128-138.
    >> Share

    January 2023
  26. SILVAIN J, Cayla G, Ferrari E, Range G, et al
    betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
    Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
    >> Share

  27. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    >> Share

  28. BHATT AS, Daniels LB, de Lemos J, Goodrich E, et al
    Multi-Marker Risk Assessment in Patients Hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Am Heart J. 2023 Jan 17:S0002-8703(22)00334-9. doi: 10.1016/j.ahj.2022.
    >> Share

  29. CHOUAIRI F, Pinsker B, Fudim M, Miller PE, et al
    Trends in Outcomes and Resource Utilization for Acute Myocardial Infarction Admissions During the COVID-19 Pandemic.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00012-1. doi: 10.1016/j.ahj.2023.
    >> Share

  30. BRANCH KRH, Probstfield JL, Bosch J, Bhatt DL, et al
    Total Events and Net Clinical Benefit of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Am Heart J. 2023 Jan 13:S0002-8703(23)00015-7. doi: 10.1016/j.ahj.2023.
    >> Share

  31. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    >> Share

  32. SPAULDING C, Krackhardt F, Bogaerts K, Urban P, et al
    Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00010-8. doi: 10.1016/j.ahj.2023.
    >> Share

  33. MOLLER JE, Gerke O
    Danish-German cardiogenic shock trial-DanGer shock: Trial design update.
    Am Heart J. 2023;255:90-93.
    >> Share

  34. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Nestelberger T, et al
    Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm.
    Am Heart J. 2023;255:58-70.
    >> Share

    December 2022
  35. DELEWI R, Vogel RF, Wilschut JM, Lemmert ME, et al
    Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00335-0. doi: 10.1016/j.ahj.2022.
    >> Share

  36. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    >> Share

  37. EKMEJIAN A, Allahwala U, Ward M, Bhindi R, et al
    Impact of coronary disease patterns, anatomical factors, micro-vascular disease and non-coronary cardiac factors on invasive coronary physiology.
    Am Heart J. 2022 Dec 9:S0002-8703(22)00327-1. doi: 10.1016/j.ahj.2022.
    >> Share

  38. LIU J, Wang B, Li Y, Yan X, et al
    Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
    >> Share

  39. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    >> Share

  40. ANTHOPOLOS R, Maron DJ, Bangalore S, Reynolds HR, et al
    ISCHEMIA-EXTEND studies: Rationale and design.
    Am Heart J. 2022;254:228-233.
    >> Share

  41. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    >> Share

    November 2022
  42. RAMUNDDAL T, Holck EN, Karim S, Eftekhari A, et al
    International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions with Myocardial Ischemia - ISCHEMIA-CTO Trial - Rationale and Design.
    Am Heart J. 2022 Nov 21:S0002-8703(22)00298-8. doi: 10.1016/j.ahj.2022.
    >> Share

  43. CARSON JL, Brooks MM, Chaitman BR, Alexander JH, et al
    Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial.
    Am Heart J. 2022 Nov 20:S0002-8703(22)00297-6. doi: 10.1016/j.ahj.2022.
    >> Share

  44. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    >> Share

  45. SNAVELY AC, Paradee BE, Ashburn NP, Allen BR, et al
    Derivation and validation of a high sensitivity troponin-T HEART pathway.
    Am Heart J. 2022;256:148-157.
    >> Share

  46. SPIRITO A, Sticchi A, Praz F, Grani C, et al
    Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes.
    Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00291.
    >> Share

  47. DE CARVALHO FPC, Hueb W, Lima EG, Rezende PC, et al
    Cardiovascular Events in Patients with Coronary Artery Disease with and Without Myocardial Ischemia: Long-Term Follow-Up.
    Am Heart J. 2022 Nov 15. pii: S0002-8703(22)00293.
    >> Share

  48. KOIVUNEN M, Tynkkynen J, Oksala N, Eskola M, et al
    Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction.
    Am Heart J. 2022 Nov 13. pii: S0002-8703(22)00290.
    >> Share

  49. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
    Predicting left main stenosis in stable ischemic heart disease using logistic regression and boosted trees.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00289.
    >> Share

  50. CORNELISSEN A, Guo L, Neally SJ, Kleinberg L, et al
    Relationships Between Neighborhood Disadvantage and Cardiovascular Findings at Autopsy in Subjects with Sudden Death.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00284.
    >> Share

  51. NISHIZAKI Y, Miyauchi K, Iwata H, Inoue T, et al
    Study Protocol and Baseline Characteristics of Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, The Combination of a Randomized Control Trial and an Observational Bioma
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00282.
    >> Share

  52. NOUHRAVESH N, Strange JE, Tonnesen J, Holt A, et al
    Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study.
    Am Heart J. 2022 Nov 9. pii: S0002-8703(22)00281.
    >> Share

  53. YEN TH, Yen JS
    Chelation trial in patients with cardiovascular disease.
    Am Heart J. 2022 Nov 3. pii: S0002-8703(22)00279.
    >> Share

  54. GARCIA H, Springer B, Vengrenyuk A, Krishnamoorthy P, et al
    Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project.
    Am Heart J. 2022;253:30-38.
    >> Share

    October 2022
  55. FROBERT O, Gotberg M, Erlinge D, Akhtar Z, et al
    Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial.
    Am Heart J. 2022 Oct 21. pii: S0002-8703(22)00198.
    >> Share

  56. GASPARDONE C, Romagnolo D, Fasolino A, Falasconi G, et al
    A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction.
    Am Heart J. 2022 Oct 19. pii: S0002-8703(22)00272.
    >> Share

  57. WOLNY R, Niedziela J, Desperak P, Kwiecinski J, et al
    Infarct-related artery and long-term mortality following recurrent ST-segment elevation myocardial infarction. Insights from a Polish nationwide registry.
    Am Heart J. 2022 Oct 12. pii: S0002-8703(22)00200.
    >> Share

  58. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
    On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
    >> Share

  59. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    >> Share

  60. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    >> Share

  61. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    >> Share

  62. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    >> Share

  63. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    The trial to assess chelation therapy 2 (TACT2): Rationale and design.
    Am Heart J. 2022;252:1-11.
    >> Share

    September 2022
  64. DESAI RJ, Glynn RJ, Everett BM, Schneeweiss S, et al
    Comparative effectiveness of empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
    Am Heart J. 2022 Sep 20. pii: S0002-8703(22)00193.
    >> Share

  65. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    >> Share

  66. KAPUR NK, Kim RJ, Moses JW, Stone GW, et al
    Primary Left Ventricular Unloading with Delayed Reperfusion in Patients with Anterior ST-Elevation Myocardial Infarction: Rationale and Design of the STEMI-DTU Randomized Pivotal Trial.
    Am Heart J. 2022 Sep 1. pii: S0002-8703(22)00184.
    >> Share

    August 2022
  67. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    >> Share

  68. KRANENDONK J, Willems LH, Vijver-Coppen RV, Coenen M, et al
    CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD).
    Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00163.
    >> Share

  69. UKAH UV, Li X, Wei SQ, Healy-Profitos J, et al
    Black-White disparity in severe cardiovascular maternal morbidity: a systematic review and meta-analysis.
    Am Heart J. 2022 Aug 6. pii: S0002-8703(22)00162.
    >> Share

  70. SHAVADIA JS, Wilson J, Edmonston D, Platt A, et al
    Corrigendum to "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease" [Am Heart J (2021) 231:36-44].
    Am Heart J. 2022 Aug 4. pii: S0002-8703(22)00142.
    >> Share

    July 2022
  71. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    >> Share

  72. SHAH N, Ghazi L, Yamamoto Y, Martin M, et al
    Rationale and Design of a Pragmatic Trial Aimed at Improving Treatment of Hyperlipidemia in Outpatients with Very High Risk Atherosclerotic Cardiovascular Disease: A PRagmatic Trial Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-L
    Am Heart J. 2022 Jul 13. pii: S0002-8703(22)00146.
    >> Share

  73. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
    Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
    >> Share

  74. AKINYELURE OP, Colantonio LD, Chaudhary NS, Jaeger BC, et al
    Inflammation biomarkers and incident coronary heart disease: The Reasons for Geographic and Racial Differences in Stroke Study.
    Am Heart J. 2022 Jul 7. pii: S0002-8703(22)00144.
    >> Share

    June 2022
  75. MOHEBI R, McCarthy CP, Gaggin HK, Kimmenade RRJV, et al
    Inflammatory Biomarkers and Risk of Cardiovascular Events in Patients Undergoing Coronary Angiography.
    Am Heart J. 2022 Jun 23. pii: S0002-8703(22)00128.
    >> Share

  76. DIXON D, Patel J, Spence R, Talasaz A, et al
    Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
    Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
    >> Share

  77. VOGEL RF, Delewi R, Wilschut JM, Lemmert ME, et al
    Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial.
    Am Heart J. 2022 Jun 4. pii: S0002-8703(22)00116.
    >> Share

    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.
    >> Share

  79. ISLEK D, Alonso A, Rosamond W, Kucharska-Newton A, et al
    Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC Community Surveillance Study.
    Am Heart J. 2022 Jun 1. pii: S0002-8703(22)00114.
    >> Share

    May 2022
  80. MAZHAR F, Hjemdahl P, Clase CM, Johnell K, et al
    Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00115.
    >> Share

  81. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    >> Share

  82. KHAN MINHAS AM, Ijaz SH, Javed N, Sheikh AB, et al
    National Trends and Disparities in Statin Use for Ischemic Heart Disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00109.
    >> Share

  83. OMEROVIC E, Erlinge D, Koul S, Frobert O, et al
    Rationale and Design of Switch Swedeheart: A Registry-Based, Stepped-Wedge, Cluster-Randomized, Open-Label Multicenter Trial to Compare Prasugrel and Ticagrelor for Treatment of Patients with Acute Coronary Syndrome.
    Am Heart J. 2022 May 26. pii: S0002-8703(22)00112.
    >> Share

  84. BLUMENTHAL JA, Smith PJ, Jiang W, Hinderliter A, et al
    Longer Term Benefits of Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: Six Month Follow-up of the UNWIND Randomized Clinical Trial.
    Am Heart J. 2022 May 21. pii: S0002-8703(22)00106.
    >> Share

  85. NEWMAN JD, Douglas PS, Zhbannikov I, Ferencik M, et al
    Associations of a Polygenic Risk Score with Coronary Artery Disease Phenotypes in The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial.
    Am Heart J. 2022 May 20. pii: S0002-8703(22)00104.
    >> Share

  86. HARRINGTON J, Udell JA, Jones WS, Anker SD, et al
    Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial.
    Am Heart J. 2022 May 17. pii: S0002-8703(22)00095.
    >> Share

  87. CANTOR WJ, Tan M, Berwanger O, Lavi S, et al
    Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00089.
    >> Share

  88. O'DONOGHUE ML, Lopez JAG, Knusel B, Gencer B, et al
    Study Design and Rationale for the OCEAN(a)-DOSE (Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction-DOSE Finding Study) Trial.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00086.
    >> Share

  89. FORREST IS, Chan L, Chaudhary K, Saha A, et al
    Genome-First Recall of Healthy Individuals by Polygenic Risk Score Reveals Differences in Coronary Artery Calcium.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00081.
    >> Share

  90. DENOBLE AE, Goldstein SA, Wein MLE, Grotegut CA, et al
    Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00084.
    >> Share

  91. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    >> Share

    April 2022
  92. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    >> Share

  93. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    >> Share

    March 2022
  94. UDELL JA, Lu D, Bagai A, Dodson JA, et al
    Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction.
    Am Heart J. 2022 Mar 23. pii: S0002-8703(22)00056.
    >> Share

  95. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
    Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
    Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
    >> Share

  96. ERQOU S, Papaila A, Halladay C, Ge A, et al
    Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Mar 19. pii: S0002-8703(22)00054.
    >> Share

  97. GENEREUX P, Chernin G, Assali AR, Peruga JZ, et al
    Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.
    Am Heart J. 2022 Mar 16. pii: S0002-8703(22)00052.
    >> Share

  98. GENEREUX P, Kirtane AJ, Kandzari DE, Armstrong EJ, et al
    Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial.
    Am Heart J. 2022 Mar 11. pii: S0002-8703(22)00051.
    >> Share

  99. TIAN X, Zuo Y, Chen S, Meng X, et al
    Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults.
    Am Heart J. 2022 Mar 3. pii: S0002-8703(22)00047.
    >> Share

  100. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
    The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
    Am Heart J. 2022;245:136-148.
    >> Share

    February 2022
  101. VERMA KP, Marwick T, Duarte C, Meikle P, et al
    Use of Coronary Computed Tomography or Polygenic Risk Scores to Prompt Action to Reduce Coronary Artery Disease Risk: The CAPAR-CAD Trial.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00040.
    >> Share

  102. COUCH SC, Helsley RN, Siegel FU, Saelens BE, et al
    Design and Rationale for the Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction Trial.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00044.
    >> Share

  103. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    >> Share

  104. CHO MS, Kang DY, Oh YS, Lee CH, et al
    Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
    >> Share

  105. SIDHU MS, Alexander KP, Huang Z, O'Brien SM, et al
    Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00026.
    >> Share

  106. HASSAN R, Riehl-Tonn V, Dumanski SM, Lyons KJ, et al
    Female Sex-Specific Cardiovascular Risk Factors and Heart Failure Practice Guidelines.
    Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00008.
    >> Share

  107. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
    Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
    Am Heart J. 2022;244:125-134.
    >> Share

    January 2022
  108. JAIN B, Bajaj SS, Paguio JA, Yao JS, et al
    Socioeconomic Disparities in Healthcare Utilization for Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Jan 27. pii: S0002-8703(22)00011.
    >> Share

  109. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    >> Share

  110. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
    Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial.
    Am Heart J. 2022 Jan 20. pii: S0002-8703(22)00009.
    >> Share

  111. TIES D, van Dorp P, Pundziute G, van der Aalst CM, et al
    Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
    Am Heart J. 2022 Jan 13. pii: S0002-8703(22)00005.
    >> Share

  112. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    >> Share

  113. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
    Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
    >> Share

  114. HARIRI E, Kassas I, Hammoud MA, Hansra B, et al
    Same Day Discharge Following Non-elective PCI for Non-ST Elevation Acute Coronary Syndromes.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00497.
    >> Share

  115. HARA H, Serruys PW, O'Leary N, Gao C, et al
    Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
    >> Share

  116. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
    Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
    Am Heart J. 2022;243:187-200.
    >> Share

    December 2021
  117. RIFAI MA, Mahtta D, Ramsey DJ, Lee MT, et al
    nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00480.
    >> Share

  118. HSU B, Carcel C, Wang X, Peters SAE, et al
    Erratum to "Sex differences in emergency medical services management of patients with myocardial infarction: Analysis of routinely collected data for over 110,000 patients" [Am Heart J (2021) 87-91].
    Am Heart J. 2021 Dec 24. pii: S0002-8703(21)00451.
    >> Share

  119. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
    Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
    Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
    >> Share

  120. SIDHU MS, Lyubarova R, Bangalore S, Bonaca MP, et al
    Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00478.
    >> Share

  121. VEMULAPALLI S, Kerr MSD, Roberts GJ, Prillinger JB, et al
    Tricuspid Valve Disease Prevalence and the Impact of Tricuspid Valve Surgery on Cardiovascular Events and Hospital Resource Use in Medicare Beneficiaries.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00469.
    >> Share

  122. PASALA S, Cooper LB, Psotka MA, Sinha SS, et al
    The Influence of Heart Failure on Clinical and Economic Outcomes among Older Adult >/=75 Years of Age with Acute Myocardial Infarction.
    Am Heart J. 2021 Dec 16. pii: S0002-8703(21)00474.
    >> Share

  123. SIEGMUND AS, Pieper PG, Bilardo CM, Gordijn SJ, et al
    Cardiovascular Determinants of Impaired Placental Function in Women with Cardiac Dysfunction.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00473.
    >> Share

  124. ACQUAH I, Hagan K, Valero-Elizondo J, Javed Z, et al
    Delayed Medical Care due to Transportation Barriers Among Adults with Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00472.
    >> Share

  125. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    >> Share

  126. BHASIN S, Lincoff AM, Basaria S, Bauer DC, et al
    Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study.
    Am Heart J. 2021 Dec 3. pii: S0002-8703(21)00467.
    >> Share

  127. MONTOY JCC, Shen YC, Krumholz HM, Hsia RY, et al
    Association of STEMI regionalization of care with de facto NSTEMI regionalization.
    Am Heart J. 2021;242:1-5.
    >> Share

    November 2021
  128. AKHABUE E, Wong M, Mehta R, Isakova T, et al
    Fibroblast Growth Factor-23 and Subclinical Markers of Cardiac Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Am Heart J. 2021 Nov 30. pii: S0002-8703(21)00460.
    >> Share

  129. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    >> Share

  130. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    >> Share

  131. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
    Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
    Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
    >> Share

  132. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.
    >> Share

  133. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
    The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
    Am Heart J. 2021;241:92-100.
    >> Share

  134. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
    Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
    Am Heart J. 2021;241:101-107.
    >> Share

  135. POVSIC TJ, Henry TD, Ohman EM, Pepine CJ, et al
    Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
    Am Heart J. 2021;241:38-49.
    >> Share

    October 2021
  136. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
    Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
    >> Share

  137. AMINIAN A, Sgueglia GA, Wiemer M, Gasparini GL, et al
    Distal versus conventional radial access for coronary angiography and intervention: design and rationale of DISCO RADIAL Study.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00432.
    >> Share

  138. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    >> Share

  139. CHACIN-SUAREZ A, Grace SL, Anchique-Santos C, Supervia M, et al
    Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison.
    Am Heart J. 2021;240:16-27.
    >> Share

    September 2021
    Influenza Vaccination Among Adults with Cardiovascular Disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019.
    Am Heart J. 2021 Sep 29. pii: S0002-8703(21)00233.
    >> Share

  141. CAINZOS-ACHIRICA M, Anugula D, Mszar R, Grandhi G, et al
    Rationale and Pathways Forward in the Implementation of Coronary Artery Calcium-Based Enrichment of Randomized Trials.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00235.
    >> Share

  142. SALAH HM, Khan Minhas AM, Khan MS, Khan SU, et al
    Trends in Hospitalizations for Heart Failure, Acute Myocardial Infarction, and Stroke in the United States from 2004-2018.
    Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00238.
    >> Share

  143. YIN Y, Fang C, Jiang S, Wang J, et al
    In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging.
    Am Heart J. 2021 Sep 25. pii: S0002-8703(21)00236.
    >> Share

    July 2021
  144. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    >> Share

    June 2021
  145. ABE M, Ozaki Y, Takahashi H, Ishii M, et al
    Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy.
    Am Heart J. 2021 Jun 23. pii: S0002-8703(21)00165.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016